Studying The ‘Magic’ In Shrooms: New Research Will Assess Origin Of Psychedelic Properties
[ad_1] Psychedelic -or psilocybin- mushrooms have demonstrated a potential to treat such conditions as depression, anxiety and addiction, yet they are still a mystery in terms of how they evolved and what role they play…
These States Have Marijuana Or Psychedelics Legalization Bills On The Ballot For November Elections
[ad_1] Five states are preparing to vote this November for cannabis legalization – Arkansas, Maryland, Missouri North Dakota and South Dakota- while Colorado could end up legalizing psychedelics. Should the five marijuana initiatives pass next month,…
Psyched: VC Fund Invests $50M In Psychedelics, Musk’s ‘Exploratory Journeys’, Native American Use Of Peyote And More – Compass Pathways (NASDAQ:CMPS), AdvisorShares Psychedelics ETF (ARCA:PSIL)
[ad_1] Palo Santo Closes $50M Investment Fund Palo Santo, a venture capital fund focused on backing and building emerging psychedelic therapeutics companies, recently announced the closing of its $50 million…
Mass-Scale Psilocin Clinical Supplies Are Ready For Upcoming Trials – Lobe Sciences (OTC:LOBEF)
[ad_1] Canadian biotech company Lobe Sciences Ltd. LOBEF has completed the synthesis of bulk L-130, the company’s proprietary form of psilocin, as well as supplies for its upcoming clinical trials that will assess pharmacokinetics,…
Clinical Trial Will Evaluate Psilocybin-Assisted Therapy For Cannabis Use Disorder
[ad_1] Consumer health and wellness company LOVE Pharma Co.’s subsidiary The MicroDoz Therapy Inc. is sponsoring a soon-to-commence clinical trial of psilocybin-assisted therapy for cannabis use disorder, to be conducted…
Can Ketamine Treat Alcohol Addiction? In-Clinic Therapy Vs. Retreats – Awakn Life Sciences (OTC:AWKNF)
[ad_1] (Part four of a four-part series – Read part three) The reason why companies offering psychedelic-assisted therapy only use ketamine is that at the moment it is the only one…
Psychedelics May Soon Get Therapy Operating Standards: Here’s What APPA Is And Why It Matters
[ad_1] The current state of affairs seems to show that psychedelics-assisted therapy will eventually become part of the healthcare system for those suffering from a diverse range of mental and physical…
European Psychedelics Research Group Nabs $2M In Seed Funding As Clinical Research Picks Up Speed – Mindset Pharma (OTC:MSSTF), Psyence Group (OTC:PSYGF)
[ad_1] UK psychedelics clinical research organization Clerkenwell Health raised $2.047.710 (£2.1 million) in seed funding, bringing the total to date up to $2.437.750 (£2.5 million), all of which will be used…
In Oregon You Can Get Trained To Be A Licensed Psilocybin Therapy Provider
[ad_1] Educational platform training and certifying psychedelic therapists Fluence has been selected by Oregon’s Higher Education Coordinating Commission (HECC) and the Oregon Health Authority (OHA) to be a state-licensed provider…
Psyched: CA’s Psychedelic-Assisted Treatments, Ketamine Therapy, Near-Death Experience And More – ATAI Life Sciences (NASDAQ:ATAI), Braxia Scientific (OTC:BRAXF)
[ad_1] Alberta Becomes The First Canadian Province To Regulate Psychedelics-Assisted Therapy As of January 2023, Canada’s 4th largest province will be the first to offer supervised treatments involving psychedelic substances…
Canadian ‘Shrooms Kit Company Acquires Established Dutch Farm To Expand Production – Red Light Holland (OTC:TRUFF)
[ad_1] Ontario-based producer of functional mushroom home grow kits and premium magic truffles Red Light Holland Corp. TRUFF has acquired MiniChamp B.V., a dutch home grow mushroom farm, through its…
Cannabis & Psychedelics As Effective Adjunct Medicine To Breast Cancer Therapy? Studies Say Yes
[ad_1] A recent study published by life sciences company Grace Health & Wellness aims to raise awareness on the possibility of using medical cannabis and psychedelics to propel traditional pharmaceuticals.…
Can Ketamine Treat Alcohol Addiction? Clinics & Hospitals In Europe And North America Are Already Doing It – Awakn Life Sciences (OTC:AWKNF)
[ad_1] (Part one of a four-part series) The use of psychedelic-assisted psychotherapy for the treatment of mental health conditions has become a hot topic, with a growing general sense of acceptance, public…
Maine Survey Shows Most Voters Want A New Drug Policy Approach That Includes Decriminalization
[ad_1] A recent poll, led by University of Maine professors R. Glover and K. Sporer during July and August 2021 and shared this week, found that of the 400+ Mainers, a…
PharmaTher Provides Business Highlights And Releases Audited Annual Financials – PharmaTher Holdings (OTC:PHRRF)
[ad_1] PharmaTher Holdings Ltd. PHRRF has published its operational and audited financial results for fiscal year ended May 31, 2022. The company, which focuses on delivering ketamine for treating mental health disorders closed…
Psychedelics Companies And IPs: An Extended Patent Application To Protect Multiple LSD Derivatives – BetterLife Pharma (OTC:BETRF)
[ad_1] In parallel with working towards discovering and advancing therapeutic psychedelics, biopharma companies are continuously protecting their findings. The emerging biotech BetterLife Pharma Inc. BETRF has filed an international PCT along…
Psychedelics Capital Markets: Silo Pharma’s IPO, $5M Common Stock Offering – (SILO)
[ad_1] Developmental-stage biopharma company Silo Pharma Inc. SILO announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock at $5.00 per share, to begin trading…
Canadian Psychedelics Firm And Queens College Develop New Transdermal Drug Delivery System – Biomind Labs (OTC:BMNDF)
[ad_1] Life and sciences R&D company Biomind Labs Inc. BMNDF received a Controlled Substances License to begin an eight-month exclusive collaboration with Queen’s University of Belfast to produce and evaluate rapidly-dissolving…
Psychedelics Biotechs Clearmind And Mydecine Share Consolidation And Subscription Agreements – Clearmind Medicine (OTC:CMNDF), Mydecine Innovations Gr (OTC:MYCOF)
[ad_1] In connection with recent stock splits, psychedelics biotech Clearmind Medicine Inc. CMNDF announced it will proceed with the consolidation of all its issued and outstanding common shares on a 1:30…
Is Psilocybin Therapy A Potential Treatment For Fibromyalgia & Binge Eating Disorder? – Tryp Therapeutics (OTC:TRYPF)
[ad_1] Clinical-stage developer of psychedelic compounds Tryp Therapeutics Inc. TRYPF filed two provisional patent applications – one for psilocybin therapy for fibromyalgia and another expanding psilocybin-based TRP-8803 development’s IP. Tryp’s Psilocybin-For-Neuropsychiatric Disorders…
Magic Mushrooms For Anorexia? Clinical Study Receives FDA Approval For Phase 2 Trial
[ad_1] Origin Therapeutics Holdings Inc. ORIG, a psychedelics industry-focused investment issuer, announced that one of its portfolio companies, Xpira Pharmaceuticals, has obtained approval from the FDA for its first Investigational New Drug (IND) application for a Phase…
Clinical Study On DMT Inhaled Product For Treatment-Resistant Depression Completes Dosing Stage – Biomind Labs (OTC:BMNDF)
[ad_1] Biomind Labs Inc. BMNDF, a life sciences company developing medicinal next-generation psychedelics, completed the dose administration of 30 healthy subjects within its Phase 2 clinical trial of DMT-based proprietary…
Ketamine Therapy Growing In US And Canada With This Novel Montreal Clinic – Delic Hldgs (OTC:DELCF), Numinus Wellness (OTC:NUMIF)
[ad_1] Legal ketamine-assisted therapy for people with diagnosed mental health conditions continues to expand throughout the U.S. and Canada. Numinus Wellness Inc. NUMIF announced the opening of a second Canada-based clinic…
Canada Studies Effects Of Psilocybin For COVID Frontline Healthcare Workers In Phase 2 Clinical Trial
[ad_1] Alberta-based ATMA Journey Centers Inc. has received Health Canada’s approval to move forward with its N500 Phase II psilocybin clinical study investigating the potential relief of COVID-19-associated mental health…
Awakn Shares Its Q2 2022 Results, Showing Consistent Growth On Its Second Full Financial Year – Awakn Life Sciences (OTC:AWKNF)
[ad_1] Biotech firm leading the Alcohol Use Disorder (AUD) treatment Awakn Life Sciences Corp. AWKNF has announced its financial outcomes and business highlights for the three months ended July 31,…